University of Nebraska Medical Center
Omaha, NE, United States
Dr. Mikuls is a native of Omaha, Nebraska, receiving his degrees from Santa Clara University (B.S.), the University of Nebraska Medical Center (M.D.), and the University of Alabama at Birmingham (M.S.P.H.). He completed his medical residency, including a chief resident year, at the University of Nebraska Medical Center (UNMC) and his training in immunology & rheumatology at UAB in Birmingham, Alabama. He is currently the Stokes-Shackleford Professor of Rheumatology at UNMC in Omaha.
Dr. Mikuls is an epidemiologist and rheumatologist, with research interests focused on disease epidemiology, pathogenesis and outcomes in rheumatoid arthritis and gout. He currently leads research efforts of the Nebraska Arthritis Outcomes Research Center and receives active research support from the NIH (NIGMS, NIAMS), VA, Rheumatology Research Foundation, US Department of Defense, and industry. He founded and directs the national VA Rheumatoid Arthritis Registry (VARA) and serves as Director of the Professional Development core for the NIGMS-funded Great Plains IDeA CTR.
Monday, November 13, 2023
7:30 AM – 7:50 AM PT
Disclosure(s): Elsevier: Royalties (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Ongoing); UCB Pharma: Consultant (Ongoing); Wolters Kluwer Health (UpToDate): Royalties (Ongoing)
2140: Serum Alarmins and the Risk of Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Tuesday, November 14, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Elsevier: Royalties (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Ongoing); UCB Pharma: Consultant (Ongoing); Wolters Kluwer Health (UpToDate): Royalties (Ongoing)
Pharmacist-Led Interventions in Rheumatology: Lessons Learned in Gout
Tuesday, November 14, 2023
12:30 PM – 12:45 PM PT
Disclosure(s): Elsevier: Royalties (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Ongoing); UCB Pharma: Consultant (Ongoing); Wolters Kluwer Health (UpToDate): Royalties (Ongoing)